Search alternatives:
significant association » significantly associated (Expand Search)
association decrease » association areas (Expand Search), association created (Expand Search), associated increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant association » significantly associated (Expand Search)
association decrease » association areas (Expand Search), association created (Expand Search), associated increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
-
821
Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects.
Published 2024“…Asterisks in panels D and E indicate statistically significant difference relative to wild type, Z-test for proportions (***<i>p</i> < 0.0001). …”
-
822
-
823
-
824
-
825
-
826
-
827
-
828
-
829
-
830
-
831
-
832
-
833
Characteristics of study participants in women according to frailty groups.
Published 2025Subjects: -
834
-
835
-
836
-
837
-
838
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
839
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
840